Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL(pro) Reporter Assay

por Froggatt, Heather M., Heaton, Brook E., Heaton, Nicholas S.
Publicado 2020

Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity

por Froggatt, Heather M., Burke, Kaitlyn N., Chaparian, Ryan R., Miranda, Hector A., Zhu, Xinyu, Chambers, Benjamin S., Heaton, Nicholas S.
Publicado 2021

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

por Drayman, Nir, DeMarco, Jennifer K., Jones, Krysten A., Azizi, Saara-Anne, Froggatt, Heather M., Tan, Kemin, Maltseva, Natalia Ivanovna, Chen, Siquan, Nicolaescu, Vlad, Dvorkin, Steve, Furlong, Kevin, Kathayat, Rahul S., Firpo, Mason R., Mastrodomenico, Vincent, Bruce, Emily A., Schmidt, Madaline M., Jedrzejczak, Robert, Muñoz-Alía, Miguel Á., Schuster, Brooke, Nair, Vishnu, Han, Kyu-yeon, O’Brien, Amornrat, Tomatsidou, Anastasia, Meyer, Bjoern, Vignuzzi, Marco, Missiakas, Dominique, Botten, Jason W., Brooke, Christopher B., Lee, Hyun, Baker, Susan C., Mounce, Bryan C., Heaton, Nicholas S., Severson, William E., Palmer, Kenneth E., Dickinson, Bryan C., Joachimiak, Andrzej, Randall, Glenn, Tay, Savaş
Publicado 2021